profilePage

Founder and COO of Sentinel Oncology, a small molecule drug discovery organisation dedicated to the development and commercialization of new therapeutics to treat cancer patients for whom there is currently an unmet medical need. Sentinel Oncology was founded in 2005 in Cambridge, UK and it's portfolio features two programmes progressing towards IND. In addition, the portfolio includes a novel approach, “Targeted Synergy” that is designed to enhance therapeutic index by delivering the effects of drugs directly to the tumour.
Sentinel oncology is a fully integrated drug discovery company seeking to develop high quality drug candidates for partnering with the biotechnology and pharmaceutic

�ݺ�ߣ